8-K Announcements
6Material company update
May 7, 2026·SEC
Material company update
Mar 16, 2026·SEC
Material company update
Feb 13, 2026·SEC
Varex Imaging Corporation(VREX)Earnings, Financials & Key Ratios
VREX•NASDAQ
$11.83
$496M mkt cap·Price updated May 7, 2026
AboutVarex Imaging Corporation designs and manufactures X-ray imaging components. The company operates in two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components comprising X-ray tubes, digital detectors, high voltage connectors, image-processing software and workstations, 3D reconstruction and computer-aided diagnostic software, collimators, automatic exposure control devices, generators, heat exchangers, ionization chambers, and buckys. This segment's products are used in a range of applications, including radiographic and fluoroscopic imaging, mammography, computed tomography, radiation therapy, oncology, CT, cardiac, surgery, dental, computer-aided detection, and other diagnostic radiography uses. The Industrial segment designs, manufactures, sells, and services Linatron X-ray accelerators, X-ray tubes, digital detectors, and high voltage connectors for use in security and industrial inspection applications, such as airport security, cargo screening at ports and borders, and nondestructive testing and examination in various applications. Varex Imaging Corporation sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. The company has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was founded in 2016 and is based in Salt Lake City, Utah.Show more
- Revenue$845M+4.1%
- EBITDA-$600K-100.9%
- Net Income-$70M-47.4%
- EPS (Diluted)-1.70-45.3%
- Gross Margin34.39%+8.6%
- EBITDA Margin-0.07%-100.9%
- Operating Margin-3.29%-183.2%
- Net Margin-8.32%-41.5%
- ROE-13.57%-60.8%
- ROIC-2.62%-195.0%
- Debt/Equity0.83-3.6%
- Interest Coverage-0.67-165.3%
VREX Key Insights
Varex Imaging Corporation (VREX) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 1.0x book value
✗Weaknesses
No significant weaknesses identified
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
VREX Price & Volume
Varex Imaging Corporation (VREX) stock price & volume — 10-year historical chart
Loading chart...
VREX Growth Metrics
Varex Imaging Corporation (VREX) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years2.94%
5 Years2.73%
3 Years-0.58%
TTM4.05%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM11.46%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM14.62%
Return on Capital
10 Years5.89%
5 Years4.79%
3 Years2.51%
Last Year-2.86%
VREX Recent Earnings
Varex Imaging Corporation (VREX) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 9/12 qtrs (75%)●Beat Revenue 8/12 qtrs (67%)
Q1 2026Latest
Feb 10, 2026EPS
$0.19
Est $0.14
+35.7%
Revenue
$210M
Est $208M
+0.9%
Q4 2025
Nov 18, 2025EPS
$0.37
Est $0.18
+105.6%
Revenue
$229M
Est $206M
+11.2%
Q3 2025
Aug 7, 2025EPS
$0.18
Est $0.04
+350.0%
Revenue
$203M
Est $219M
-7.4%
Q2 2025
May 8, 2025EPS
$0.26
Est $0.14
+85.7%
Revenue
$213M
Est $209M
+1.7%
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q1 2026Latest | Feb 10, 2026 | $0.19vs $0.14+35.7% | $210Mvs $208M+0.9% |
| Q4 2025 | Nov 18, 2025 | $0.37vs $0.18+105.6% | $229Mvs $206M+11.2% |
| Q3 2025 | Aug 7, 2025 | $0.18vs $0.04+350.0% | $203Mvs $219M-7.4% |
| Q2 2025 | May 8, 2025 | $0.26vs $0.14+85.7% | $213Mvs $209M+1.7% |
Based on last 12 quarters of dataView full earnings history →
VREX Peer Comparison
Varex Imaging Corporation (VREX) competitors in Imaging, radiation, and oncology devices — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 XRAY | 2.2B | 10.96 | -3.65 | -2.98% | -17.06% | -41.19% | 1.84 | |
 NNOX | 115.07M | 1.76 | -1.93 | 13.91% | -452.82% | -35.55% | 0.04 | |
 ATEC | 1.17B | 7.75 | -8.07 | 24.95% | -21.07% | -443.09% | 17.21 | |
 HOLX | 16.97B | 76.01 | 30.53 | 1.74% | 13.18% | 11.01% | 0.52 | |
 ISRG | 161.07B | 453.49 | 57.62 | 20.51% | 28.15% | 16.89% | 0.02 | |
 NVST | 4.04B | 24.29 | 86.73 | 8.32% | 2.41% | 2.18% | 0.55 | |
 GE | 316.2B | 302.63 | 37.09 | 18.48% | 17.91% | 45.85% | 1.08 | |
 GEHC | 27.9B | 61.34 | 13.48 | 4.84% | 7.54% | 14.45% | 0.94 |
Compare VREX vs Peers
Varex Imaging Corporation (VREX) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
VREX Income Statement
Varex Imaging Corporation (VREX) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Oct'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 698.1M | 773.4M | 780.6M | 738.3M | 818.1M | 859.4M | 893.4M | 811M | 844.6M | 857.5M |
| Revenue Growth % | 12.58% | 10.79% | 0.93% | -5.42% | 10.81% | 5.05% | 3.96% | -9.22% | 4.14% | 4.05% |
| Cost of Goods Sold | 444.6M | 519.5M | 523.9M | 548.1M | 546.6M | 575.9M | 603.1M | 554.1M | 554.1M | 569.8M |
| COGS % of Revenue | 63.69% | 67.17% | 67.12% | 74.24% | 66.81% | 67.01% | 67.51% | 68.32% | 65.61% | - |
| Gross Profit | 253.5M▲ 0% | 253.9M▲ 0.2% | 256.7M▲ 1.1% | 190.2M▼ 25.9% | 271.5M▲ 42.7% | 283.5M▲ 4.4% | 290.3M▲ 2.4% | 256.9M▼ 11.5% | 290.5M▲ 13.1% | 287.7M▲ 0% |
| Gross Margin % | 36.31% | 32.83% | 32.88% | 25.76% | 33.19% | 32.99% | 32.49% | 31.68% | 34.39% | 33.55% |
| Gross Profit Growth % | 2.05% | 0.16% | 1.1% | -25.91% | 42.74% | 4.42% | 2.4% | -11.51% | 13.08% | - |
| Operating Expenses | 169.8M | 209.4M | 206.2M | 223.9M | 197.4M | 195.3M | 213.2M | 224.8M | 318.3M | 319M |
| OpEx % of Revenue | 24.32% | 27.08% | 26.42% | 30.33% | 24.13% | 22.73% | 23.86% | 27.72% | 37.69% | - |
| Selling, General & Admin | 102.5M | 126.4M | 128.1M | 142.2M | 125.5M | 118.3M | 128.4M | 137.8M | 133.3M | 135.6M |
| SG&A % of Revenue | 14.68% | 16.34% | 16.41% | 19.26% | 15.34% | 13.77% | 14.37% | 16.99% | 15.78% | - |
| Research & Development | 67.3M | 83M | 78.1M | 78.9M | 71.9M | 77M | 84.8M | 87M | 91.1M | 89.5M |
| R&D % of Revenue | 9.64% | 10.73% | 10.01% | 10.69% | 8.79% | 8.96% | 9.49% | 10.73% | 10.79% | - |
| Other Operating Expenses | 0 | 0 | 0 | 2.8M | 0 | 0 | 0 | 0 | 93.9M | 1000K |
| Operating Income | 83.7M▲ 0% | 44.5M▼ 46.8% | 8.2M▼ 81.6% | -33.7M▼ 511.0% | 74.1M▲ 319.9% | 88.2M▲ 19.0% | 77.1M▼ 12.6% | 32.1M▼ 58.4% | -27.8M▼ 186.6% | -31.3M▲ 0% |
| Operating Margin % | 11.99% | 5.75% | 1.05% | -4.56% | 9.06% | 10.26% | 8.63% | 3.96% | -3.29% | -3.65% |
| Operating Income Growth % | -23.28% | -46.83% | -81.57% | -510.98% | 319.88% | 19.03% | -12.58% | -58.37% | -186.6% | - |
| EBITDA | 111.1M | 86.7M | 47.4M | 5.8M | 111.4M | 121.8M | 110.3M | 63.2M | -600K | -17.8M |
| EBITDA Margin % | 15.91% | 11.21% | 6.07% | 0.79% | 13.62% | 14.17% | 12.35% | 7.79% | -0.07% | -2.08% |
| EBITDA Growth % | -10.69% | -21.96% | -45.33% | -87.76% | 1820.69% | 9.34% | -9.44% | -42.7% | -100.95% | -121.71% |
| D&A (Non-Cash Add-back) | 27.4M | 42.2M | 39.2M | 39.5M | 37.3M | 33.6M | 33.2M | 31.1M | 27.2M | 13.5M |
| EBIT | 87.1M | 47.4M | 42.6M | -48.2M | 67.2M | 80.9M | 61.5M | 31.8M | -23.7M | -40.5M |
| Net Interest Income | -12.1M | -21.5M | -21M | -31.3M | -43.3M | -40.6M | -25.6M | -23.8M | -27M | -20.7M |
| Interest Income | 200K | 200K | 100K | 100K | 100K | 400K | 3.7M | 7.3M | 8.5M | 4.5M |
| Interest Expense | 12.3M | 21.7M | 21.1M | 31.4M | 43.4M | 41M | 29.3M | 31.1M | 35.5M | -8.2M |
| Other Income/Expense | -8.9M | -18.8M | 0 | -38.9M | -45.5M | -43.7M | -45.8M | -27.1M | -31.4M | -23M |
| Pretax Income | 74.8M▲ 0% | 25.7M▼ 65.6% | 21.5M▼ 16.3% | -72.6M▼ 437.7% | 28.6M▲ 139.4% | 44.5M▲ 55.6% | 31.3M▼ 29.7% | 5M▼ 84.0% | -59.2M▼ 1284.0% | -75.1M▲ 0% |
| Pretax Margin % | 10.71% | 3.32% | 2.75% | -9.83% | 3.5% | 5.18% | 3.5% | 0.62% | -7.01% | -8.76% |
| Income Tax | 22.8M | -2.6M | 5.7M | -15.2M | 10.7M | 13.7M | -17.4M | 52.2M | 10.7M | 7.4M |
| Effective Tax Rate % | 30.48% | -10.12% | 26.51% | 20.94% | 37.41% | 30.79% | -55.59% | 1044% | -18.07% | -9.85% |
| Net Income | 51.6M▲ 0% | 27.5M▼ 46.7% | 15.5M▼ 43.6% | -57.9M▼ 473.5% | 17.4M▲ 130.1% | 30.3M▲ 74.1% | 48.2M▲ 59.1% | -47.7M▼ 199.0% | -70.3M▼ 47.4% | -82.7M▲ 0% |
| Net Margin % | 7.39% | 3.56% | 1.99% | -7.84% | 2.13% | 3.53% | 5.4% | -5.88% | -8.32% | -9.64% |
| Net Income Growth % | -24.67% | -46.71% | -43.64% | -473.55% | 130.05% | 74.14% | 59.08% | -198.96% | -47.38% | 11.46% |
| Net Income (Continuing) | 52M | 28.3M | 15.8M | -57.4M | 17.9M | 30.8M | 47.9M | -47.2M | -69.9M | -76.9M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 11.2M | 13.2M | 13.8M | 14.1M | 13.2M | 13.3M | 13.3M | 14.1M | 14M | 13.9M |
| EPS (Diluted) | 1.36▲ 0% | 0.72▼ 47.1% | 0.40▼ 44.4% | -1.49▼ 472.5% | 0.43▲ 128.9% | 0.73▲ 69.8% | 0.96▲ 31.5% | -1.17▼ 221.9% | -1.70▼ 45.3% | -1.97▲ 0% |
| EPS Growth % | -23.6% | -47.06% | -44.44% | -472.5% | 128.86% | 69.77% | 31.51% | -208.33% | -45.3% | 14.62% |
| EPS (Basic) | 1.37 | 0.73 | 0.41 | -1.49 | 0.44 | 0.76 | 1.20 | -1.17 | -1.70 | - |
| Diluted Shares Outstanding | 38M | 38.4M | 38.6M | 38.8M | 40.3M | 41.6M | 50.3M | 40.8M | 41.4M | 41.9M |
| Basic Shares Outstanding | 37.6M | 37.9M | 38.2M | 38.8M | 39.3M | 39.8M | 40.3M | 40.8M | 41.4M | 41.9M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
VREX Balance Sheet
Varex Imaging Corporation (VREX) balance sheet — assets, liabilities & shareholders' equity
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Oct'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 495.3M | 458.1M | 440.3M | 522M | 554.2M | 609.9M | 658.3M | 649.9M | 641.8M | 625.6M |
| Cash & Short-Term Investments | 83.3M | 51.9M | 29.9M | 100.6M | 144.6M | 89.4M | 193.9M | 200.5M | 155.1M | 88.3M |
| Cash Only | 83.3M | 51.9M | 29.9M | 100.6M | 144.6M | 89.4M | 152.6M | 168.7M | 145M | 85.3M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 41.3M | 31.8M | 10.1M | 3M |
| Accounts Receivable | 163.6M | 154M | 141M | 123.8M | 155.3M | 173.3M | 164.3M | 157.7M | 157.4M | 148.1M |
| Days Sales Outstanding | 85.54 | 72.68 | 65.93 | 61.2 | 69.29 | 73.6 | 67.13 | 70.97 | 68.02 | 62.76 |
| Inventory | 234.5M | 235.1M | 250.3M | 271.9M | 224.8M | 303.2M | 277.5M | 264.8M | 299.4M | 346.7M |
| Days Inventory Outstanding | 192.52 | 165.18 | 174.38 | 181.07 | 150.11 | 192.17 | 167.94 | 174.43 | 197.22 | 203.83 |
| Other Current Assets | 0 | 17.1M | -200K | 0 | 0 | 2.1M | 22.6M | 26.9M | 29.9M | 42.5M |
| Total Non-Current Assets | 544.8M | 530.4M | 600.5M | 617.5M | 593.3M | 574.5M | 591.3M | 567.1M | 465.6M | 463.8M |
| Property, Plant & Equipment | 148.3M | 144.9M | 142.3M | 172.9M | 164.5M | 164.5M | 172.6M | 181.7M | 187.2M | 192.4M |
| Fixed Asset Turnover | 4.71x | 5.34x | 5.49x | 4.27x | 4.97x | 5.22x | 5.18x | 4.46x | 4.51x | 4.60x |
| Goodwill | 241.9M | 243.6M | 290.8M | 293.1M | 292.2M | 284.5M | 288.5M | 291M | 198.4M | 197.8M |
| Intangible Assets | 91.3M | 73.8M | 86.3M | 67.5M | 50.7M | 33.6M | 22.4M | 16.1M | 14M | 13.2M |
| Long-Term Investments | 52.3M | 51M | 53.6M | 51.3M | 49.3M | 46.4M | 30.4M | 26.8M | 26.6M | 94.6M |
| Other Non-Current Assets | -18.5M | -6.1M | 27.5M | 32.2M | 32.6M | 43.2M | 36.1M | 46.8M | 36.5M | 145.8M |
| Total Assets | 1.04B▲ 0% | 988.5M▼ 5.0% | 1.04B▲ 5.3% | 1.14B▲ 9.5% | 1.15B▲ 0.7% | 1.18B▲ 3.2% | 1.25B▲ 5.5% | 1.22B▼ 2.6% | 1.11B▼ 9.0% | 1.09B▲ 0% |
| Asset Turnover | 0.67x | 0.78x | 0.75x | 0.65x | 0.71x | 0.73x | 0.71x | 0.67x | 0.76x | 0.79x |
| Asset Growth % | 67.11% | -4.96% | 5.29% | 9.48% | 0.7% | 3.22% | 5.5% | -2.61% | -9.01% | -60.65% |
| Total Current Liabilities | 151.8M | 152.6M | 175.1M | 160.6M | 166.6M | 173.1M | 162.8M | 195.9M | 187.2M | 195.3M |
| Accounts Payable | 58.9M | 66.3M | 58.2M | 72.9M | 58.8M | 78.2M | 64.7M | 59.1M | 69.9M | 96.4M |
| Days Payables Outstanding | 48.35 | 46.58 | 40.55 | 48.55 | 39.26 | 49.56 | 39.16 | 38.93 | 46.04 | 50.59 |
| Short-Term Debt | 20M | 25M | 30.7M | 2.5M | 2.8M | 2.1M | 5.4M | 46.3M | 6.3M | 23.3M |
| Deferred Revenue (Current) | 10.5M | 13.2M | 10.5M | 8.6M | 9.1M | 14.2M | 17.4M | 7.9M | 13M | 54.5M |
| Other Current Liabilities | 23.2M | 19.1M | 32.9M | 31.7M | 37.3M | 7.9M | 28.6M | 40.5M | 49.3M | 157.5M |
| Current Ratio | 3.26x | 3.00x | 2.51x | 3.25x | 3.33x | 3.52x | 4.04x | 3.32x | 3.43x | 3.43x |
| Quick Ratio | 1.72x | 1.46x | 1.09x | 1.56x | 1.98x | 1.77x | 2.34x | 1.97x | 1.83x | 1.83x |
| Cash Conversion Cycle | 229.7 | 191.28 | 199.77 | 193.73 | 180.14 | 216.21 | 195.91 | 206.47 | 219.2 | 216 |
| Total Non-Current Liabilities | 498.1M | 396.5M | 405.9M | 513.1M | 484.4M | 464.6M | 505.8M | 471.9M | 433.6M | 406M |
| Long-Term Debt | 463.9M | 364.8M | 364.4M | 452.8M | 431.7M | 412.3M | 441.1M | 397.1M | 366M | 23M |
| Capital Lease Obligations | 0 | 0 | 0 | 23.1M | 18.7M | 18.1M | 23.3M | 23M | 29.6M | 83.4M |
| Deferred Tax Liabilities | 29.5M | 23.2M | 9M | 2.3M | 2.2M | 500K | 0 | 1.4M | 5.5M | 19.4M |
| Other Non-Current Liabilities | 4.7M | 8.5M | 32.5M | 34.9M | 31.8M | 12.3M | 19.7M | 50.4M | 32.5M | 492.4M |
| Total Liabilities | 649.9M | 549.1M | 581M | 673.7M | 651M | 637.7M | 668.6M | 667.8M | 620.8M | 601.3M |
| Total Debt | 483.9M | 389.8M | 395.1M | 484.5M | 459.4M | 436.4M | 469.8M | 470.4M | 401.9M | 46.3M |
| Net Debt | 400.6M | 337.9M | 365.2M | 383.9M | 314.8M | 347M | 317.2M | 301.7M | 256.9M | -39M |
| Debt / Equity | 1.24x | 0.89x | 0.86x | 1.04x | 0.93x | 0.80x | 0.81x | 0.86x | 0.83x | 0.83x |
| Debt / EBITDA | 4.36x | 4.50x | 8.34x | 83.53x | 4.12x | 3.58x | 4.26x | 7.44x | - | -2.60x |
| Net Debt / EBITDA | 3.61x | 3.90x | 7.70x | 66.19x | 2.83x | 2.85x | 2.88x | 4.77x | - | 2.19x |
| Interest Coverage | 7.08x | 2.18x | 2.02x | -1.54x | 1.55x | 1.97x | 2.10x | 1.02x | -0.67x | 4.94x |
| Total Equity | 390.2M▲ 0% | 439.4M▲ 12.6% | 459.8M▲ 4.6% | 465.8M▲ 1.3% | 496.5M▲ 6.6% | 546.7M▲ 10.1% | 581M▲ 6.3% | 549.2M▼ 5.5% | 486.6M▼ 11.4% | 488.1M▲ 0% |
| Equity Growth % | -27.24% | 12.61% | 4.64% | 1.3% | 6.59% | 10.11% | 6.27% | -5.47% | -11.4% | -57.41% |
| Book Value per Share | 10.27 | 11.44 | 11.91 | 12.01 | 12.32 | 13.14 | 11.55 | 13.46 | 11.75 | 11.65 |
| Total Shareholders' Equity | 379M | 426.2M | 446M | 451.7M | 483.3M | 533.4M | 567.7M | 535.1M | 472.6M | 474.2M |
| Common Stock | 400K | 400K | 400K | 400K | 400K | 400K | 400K | 400K | 400K | 0 |
| Retained Earnings | 35.1M | 62.4M | 75.5M | 16.9M | 33.5M | 63.8M | 118.1M | 70.4M | -5.9M | -11.7M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 800K | 5.8M | -1.7M | 800K | 0 | 100K | -1.2M | -2.9M | -5.2M | -5.6M |
| Minority Interest | 11.2M | 13.2M | 13.8M | 14.1M | 13.2M | 13.3M | 13.3M | 14.1M | 14M | 13.9M |
VREX Cash Flow Statement
Varex Imaging Corporation (VREX) cash flow — operating, investing & free cash flow history
| Line item | Sep'17 | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Oct'25 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 74.6M | 85.3M | 71.9M | 13.2M | 92.6M | 16.9M | 108.4M | 47.3M | 41.7M | 41.7M |
| Operating CF Margin % | 10.69% | 11.03% | 9.21% | 1.79% | 11.32% | 1.97% | 12.13% | 5.83% | 4.94% | - |
| Operating CF Growth % | 0.54% | 14.34% | -15.71% | -81.64% | 601.52% | -81.75% | 541.42% | -56.37% | -11.84% | -451.76% |
| Net Income | 52M | 28.3M | 15.8M | -57.4M | 17.9M | 30.8M | 48.7M | -47.2M | -69.9M | -82.7M |
| Depreciation & Amortization | 27.4M | 42.2M | 39.2M | 39.5M | 37.3M | 33.6M | 33.2M | 31.1M | 27.2M | 27.1M |
| Stock-Based Compensation | 8.4M | 10M | 11.7M | 13.4M | 13.9M | 14M | 13.5M | 15.3M | 15M | 14.9M |
| Deferred Taxes | -8.9M | -7.7M | -12.9M | -3.1M | -3M | 600K | -39.5M | 37M | -500K | -200K |
| Other Non-Cash Items | 2.3M | 6.5M | 13.4M | 34.7M | 18.3M | 25.9M | 29.2M | 9.1M | 101.3M | 58.7M |
| Working Capital Changes | -6.6M | 6M | 4.7M | -13.9M | 8.2M | -88M | 23.3M | 2M | -31.4M | -20M |
| Change in Receivables | -23.1M | 9M | 14.8M | 17.7M | -32.9M | -18.1M | 9.8M | 6.7M | 100K | -3.7M |
| Change in Inventory | -4.2M | -2.4M | -11.1M | -42.7M | 42.8M | -85M | 20.2M | 6.6M | -39.9M | -16.1M |
| Change in Payables | 4.9M | 5.2M | -9M | 14.3M | -13.6M | 19.7M | -15M | -3.2M | 6.2M | 22.9M |
| Cash from Investing | -292M | -25.2M | -93.2M | -26.9M | -16.2M | -48.4M | -44.9M | -27.5M | 10.3M | -12.2M |
| Capital Expenditures | -20.2M | -20.4M | -19.8M | -23.5M | -15.1M | -21.3M | -20.7M | -26.9M | -22.9M | -28.8M |
| CapEx % of Revenue | 2.89% | 2.64% | 2.54% | 3.18% | 1.85% | 2.48% | 2.32% | 3.32% | 2.71% | - |
| Acquisitions | -271.8M | -4.8M | -73.4M | -3.4M | -1.4M | 1.1M | -1M | 900K | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 300K | -1.9M | 4.4M | -1.1M | -800K | -700K |
| Cash from Financing | 0 | -90.4M | -100K | 83.6M | -32.3M | -23.8M | -200K | -3.3M | -75.9M | -231M |
| Debt Issued (Net) | 494M | -96M | -1.6M | 109.9M | -31.6M | -29.4M | -2.4M | -1.6M | -75M | -200.8M |
| Equity Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.3M | 100K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -494M | 5.6M | 1.5M | -26.3M | -700K | 5.6M | 2.2M | -1.7M | -4.2M | -30.3M |
| Net Change in Cash | 47.4M▲ 0% | -30.8M▼ 165.0% | -22.1M▲ 28.2% | 70.8M▲ 420.4% | 44M▼ 37.9% | -55.5M▼ 226.1% | 63.4M▲ 214.2% | 16.4M▼ 74.1% | -23.3M▼ 242.1% | -244.5M▲ 0% |
| Free Cash Flow | 55M▲ 0% | 64.9M▲ 18.0% | 52.1M▼ 19.7% | -10.3M▼ 119.8% | 77.5M▲ 852.4% | -4.4M▼ 105.7% | 87.7M▲ 2093.2% | 20.4M▼ 76.7% | 18.8M▼ 7.8% | -30.8M▲ 0% |
| FCF Margin % | 7.88% | 8.39% | 6.67% | -1.4% | 9.47% | -0.51% | 9.82% | 2.52% | 2.23% | -3.59% |
| FCF Growth % | 21.41% | 18% | -19.72% | -119.77% | 852.43% | -105.68% | 2093.18% | -76.74% | -7.84% | -156.1% |
| FCF per Share | 1.45 | 1.69 | 1.35 | -0.27 | 1.92 | -0.11 | 1.74 | 0.50 | 0.45 | 0.45 |
| FCF Conversion (FCF/Net Income) | 1.45x | 3.10x | 4.64x | -0.23x | 5.32x | 0.56x | 2.25x | -0.99x | -0.59x | 0.37x |
| Interest Paid | 9.8M | 19.3M | 19.9M | 16.7M | 21.6M | 29.5M | 27.4M | 27.6M | 31.3M | 700K |
| Taxes Paid | 6M | 13.8M | 8.2M | 4.2M | 14.1M | 2.2M | 16.7M | 20.2M | 18.6M | -10M |
VREX Key Ratios
Varex Imaging Corporation (VREX) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 11.14% | 6.63% | 3.45% | -12.51% | 3.62% | 5.81% | 8.55% | -8.44% | -13.57% | -17.1% |
| Return on Invested Capital (ROIC) | 9.73% | 4.26% | 0.77% | -3.02% | 6.69% | 7.76% | 6.45% | 2.75% | -2.62% | -2.62% |
| Gross Margin | 36.31% | 32.83% | 32.88% | 25.76% | 33.19% | 32.99% | 32.49% | 31.68% | 34.39% | 33.55% |
| Net Margin | 7.39% | 3.56% | 1.99% | -7.84% | 2.13% | 3.53% | 5.4% | -5.88% | -8.32% | -9.64% |
| Debt / Equity | 1.24x | 0.89x | 0.86x | 1.04x | 0.93x | 0.80x | 0.81x | 0.86x | 0.83x | 0.83x |
| Interest Coverage | 7.08x | 2.18x | 2.02x | -1.54x | 1.55x | 1.97x | 2.10x | 1.02x | -0.67x | 4.94x |
| FCF Conversion | 1.45x | 3.10x | 4.64x | -0.23x | 5.32x | 0.56x | 2.25x | -0.99x | -0.59x | 0.37x |
| Revenue Growth | 12.58% | 10.79% | 0.93% | -5.42% | 10.81% | 5.05% | 3.96% | -9.22% | 4.14% | 4.05% |
VREX SEC Filings & Documents
Varex Imaging Corporation (VREX) SEC filings — annual & quarterly reports (10-K, 10-Q)
VREX Frequently Asked Questions
Varex Imaging Corporation (VREX) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Varex Imaging Corporation (VREX) reported $857.5M in revenue for fiscal year 2025. This represents a 25% increase from $685.2M in 2014.
Varex Imaging Corporation (VREX) grew revenue by 4.1% over the past year. Growth has been modest.
Varex Imaging Corporation (VREX) reported a net loss of $82.7M for fiscal year 2025.
Dividend & Returns
Varex Imaging Corporation (VREX) has a return on equity (ROE) of -13.6%. Negative ROE indicates the company is unprofitable.
Varex Imaging Corporation (VREX) had negative free cash flow of $30.8M in fiscal year 2025, likely due to heavy capital investments.
Explore More VREX
Varex Imaging Corporation (VREX) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates